Cartesian Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNAC and other ETFs, options, and stocks.About RNAC
Cartesian Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates.
RNAC Key Statistics
Stock Snapshot
Cartesian Therapeutics(RNAC) stock is priced at $6.00, giving the company a market capitalization of 159.05M. It carries a P/E multiple of -1.26.
On 2026-04-15, Cartesian Therapeutics(RNAC) stock moved within a range of $5.97 to $6.40. With shares now at $6.00, the stock is trading +0.5% above its intraday low and -6.3% below the session's peak.
Trading volume for Cartesian Therapeutics(RNAC) stock has reached 118.58K, versus its average volume of 156.68K.
The stock's 52-week range extends from a low of $5.60 to a high of $15.57.
The stock's 52-week range extends from a low of $5.60 to a high of $15.57.
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.